Ca(2+)-Dependent Effects of the Selenium-Sorafenib Nanocomplex on Glioblastoma Cells and Astrocytes of the Cerebral Cortex: Anticancer Agent and Cytoprotector

Despite the fact that sorafenib is recommended for the treatment of oncological diseases of the liver, kidneys, and thyroid gland, and recently it has been used for combination therapy of brain cancer of various genesis, there are still significant problems for its widespread and effective use. Amon...

Descripción completa

Detalles Bibliográficos
Autores principales: Varlamova, Elena G., Khabatova, Venera V., Gudkov, Sergey V., Turovsky, Egor A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917080/
https://www.ncbi.nlm.nih.gov/pubmed/36768736
http://dx.doi.org/10.3390/ijms24032411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917080/
https://www.ncbi.nlm.nih.gov/pubmed/36768736
http://dx.doi.org/10.3390/ijms24032411

Ejemplares similares